singl
chain
variabl
fragment
scfv
gener
join
togeth
variabl
heavi
light
chain
monoclon
antibodi
mab
via
peptid
linker
offer
advantag
parent
mab
low
molecular
weight
heterolog
product
multimer
form
multival
scfv
produc
antigen
till
date
use
differ
plant
speci
express
system
consider
improv
express
purif
strategi
scfv
last
year
grow
demand
scfv
therapeut
diagnost
field
biosynthesi
need
increas
easi
develop
mainten
multipl
transgen
plant
make
attract
express
platform
scfv
product
review
intend
provid
comprehens
inform
use
plant
express
system
produc
scfv
develop
advantag
pitfal
possibl
prospect
improv
exploit
plant
industri
level
discuss
antibodi
use
extens
medicin
diagnost
molecul
environ
cleanup
agent
biosensor
bait
purif
process
variou
commerci
industri
due
larg
size
complex
natur
extens
posttransl
modif
monoclon
antibodi
mab
therapeut
applic
produc
mostli
use
mammalian
express
system
cost
factor
involv
maintain
manufactur
unit
accord
gmp
good
manufactur
practis
regul
make
commerci
product
mab
exorbit
process
singl
chain
variabl
fragment
scfv
smallest
fragment
antibodi
antigenbind
specif
multimer
scfv
compris
one
pair
heavi
light
chain
gener
chang
length
peptid
linker
multimer
also
made
use
specif
peptid
natur
abil
induc
multival
scfv
show
affin
one
protein
time
gener
genet
engin
multival
scfv
bind
multipl
antigen
time
improv
diagnost
accuraci
antibodydepend
procedur
concept
practic
use
plant
recombin
protein
express
platform
made
signific
progress
last
two
decad
mani
antibodi
express
success
plant
differ
posttransl
modif
mammalian
cell
plant
cell
seriou
concern
use
plant
recombin
antibodi
express
genet
manipul
lead
mammalianlik
posttransl
modif
model
plant
system
result
biosynthesi
antibodi
equival
mammalian
product
even
though
biolog
activ
mab
express
success
plant
feasibl
approach
would
express
antibodi
fragment
model
plant
like
nicotiana
arabidopsi
studi
thoroughli
identifi
appropri
promot
suitabl
integr
site
host
genom
influenc
signaltag
express
viabil
subcellular
targetingsecret
recombin
protein
organspecif
express
express
transient
stabl
protein
extract
purif
strategi
differ
target
protein
review
present
comprehens
report
scfv
scfvfc
express
far
plant
system
convent
antibodi
consist
two
heavi
chain
two
light
chain
connect
disulfid
bond
antibodi
structur
divid
constant
fc
domain
crystalliz
fragment
domain
fab
fragment
antibodi
bind
fragment
contain
fv
domain
variabl
fragment
domain
end
arm
fig
human
antibodi
synthes
usual
glycosyl
fc
region
stabil
antibodi
necessari
antibodydepend
immun
respons
enzymat
cleavag
antibodi
ntermin
side
interheavi
chain
disulfid
bridg
result
format
fc
fab
fragment
two
variabl
region
fab
fragment
interact
antigen
unit
repres
smallest
function
antigenbind
domain
scfv
gener
amplifi
variabl
region
fab
fragment
mab
link
togeth
flexibl
peptid
linker
usual
gggg
fig
advanc
molecular
techniqu
improv
prospect
engin
scfv
improv
specif
avid
affin
halflif
multimer
variabl
domain
use
linker
tetramer
domain
nativ
protein
like
leucin
zipper
ctermin
fragment
protein
improv
affin
scfv
great
extent
immunogen
gener
fc
portion
antibodi
absent
convent
scfv
molecul
scfv
express
togeth
fc
region
igg
scfvfc
found
beneficiari
effector
function
mani
report
fig
antibodi
fragment
therapeut
diagnost
import
express
mammalian
system
plant
prokaryot
extens
review
biotechnolog
applic
antibodi
fragment
given
earlier
plant
express
antibodi
also
use
studi
basic
metabol
plant
term
diseas
resist
pathogen
proteinprotein
interact
specif
role
endogen
protein
metabol
process
select
modul
activ
express
mab
heterolog
product
system
precari
biolog
activ
result
molecul
depend
sever
posttransl
modif
scfv
b
repres
variabl
heavi
light
chain
connect
togeth
peptid
linker
scfv
engin
gener
multival
multidomain
structur
dimer
monospecif
c
bispecif
form
scfv
multimer
scfv
e
molecul
gener
shorten
linker
peptid
multival
f
scfv
paratop
specif
one
antigen
gener
arrang
vh
vl
differ
antibodi
specif
order
scfvfc
g
scfv
bound
fc
region
antibodi
biosynthesi
convent
antibodi
molecul
kda
mammalian
express
system
transgen
anim
highli
expens
timeconsum
scfv
smaller
size
kda
less
posttransl
modif
show
similar
specif
affin
parent
antibodi
antigen
due
smaller
size
scfv
show
rapid
blood
clearanc
use
properti
radiotherapi
diagnost
applic
better
tissu
penetr
greater
impact
use
therapeut
full
length
mab
due
rapid
blood
clearanc
vivo
avail
scfv
low
compar
mab
consid
major
drawback
scfv
order
increas
bioavail
scfv
bloodstream
diabodi
k
da
triabodi
kda
tetrabodi
kda
develop
manipul
length
linker
peptid
vh
vl
domain
use
method
facilit
multimer
scfv
molecul
fig
tandem
dimer
scfv
gener
two
differ
antibodi
sourc
also
creat
bispecif
antibodi
variat
arrang
vh
vl
sequenc
prove
effect
method
detect
specif
cell
type
fluorescencetag
scfv
dimer
fig
multival
gener
combin
code
sequenc
one
scfv
togeth
multimer
use
link
differ
moieti
one
may
target
cell
surfac
receptor
cancer
cell
bound
anticanc
drug
facilit
target
deliveri
therapeut
site
action
fig
consid
limit
convent
express
system
like
mammalian
cell
prokaryot
easi
manipul
plant
cope
mount
need
suitabl
recombin
protein
product
platform
fig
contamin
anim
pathogen
one
major
concern
use
mammalian
express
system
refut
plant
express
system
use
farm
transgen
plant
open
possibl
expand
product
target
gene
product
littl
invest
compar
convent
method
target
express
seed
oil
bodi
serv
differ
function
protein
need
transport
place
product
store
longer
express
seed
easi
purif
protein
target
oil
bodi
report
recent
past
plantbas
express
system
effici
produc
suffici
quantiti
recombin
antibodi
transient
within
short
time
span
especi
epidem
like
recent
ebola
viru
outbreak
africa
use
stabli
transform
plant
like
duckwe
rapid
multipl
rate
biomanufactur
platform
target
protein
express
within
short
period
product
increas
per
need
differ
posttransl
modif
pattern
compar
mammalian
cell
taken
care
model
plant
genom
engin
success
express
antibodi
biolog
function
similar
mammalian
product
report
plant
recent
donini
marus
review
extens
plantbas
antibodi
product
platform
includ
bryophyt
algal
speci
comprehens
list
scfv
express
plant
given
tabl
among
method
employ
transform
plant
cell
scfv
express
agrobacteriummedi
gene
transfer
top
list
represent
report
transform
along
genom
edit
techniqu
modifi
genom
host
plant
facilit
protein
express
tailormad
fashion
subject
number
recent
review
gener
agrobacterium
tumefacien
transfer
tdna
region
ti
plasmid
genom
host
plant
help
vir
gene
product
replac
tumorinduc
gene
gene
interest
within
right
left
border
cocultiv
agrobacterium
contain
modifi
ti
plasmid
vitro
rais
plant
cell
wound
tissu
lead
transfer
clone
dna
plant
cell
follow
integr
genom
method
cheap
easi
handl
produc
transgen
line
carri
one
copi
transfer
gene
transform
experi
use
model
plant
express
scfv
follow
agrobacteriummedi
gene
transfer
report
use
plant
viru
polyethylen
glycol
method
transform
tabl
model
plant
nicotiana
tabacum
benthamiana
sp
arabidopsi
thaliana
favor
express
system
scfv
fig
wellcharacter
vitro
propag
transform
mainten
method
plant
factor
behind
select
protein
express
whole
plant
tissu
leav
flower
seed
hairi
root
cultur
tobacco
tobacco
cultivar
bright
yellow
cell
fig
even
though
dearth
inform
level
express
either
due
lack
report
due
usag
measur
difficult
compar
like
tsp
mgkg
mghector
recent
report
standard
measur
show
model
plant
express
protein
good
quantiti
tobacco
plant
exploit
hairi
root
format
protein
express
rhizosecret
open
possibl
reduc
downstream
process
cost
recombin
protein
product
develop
special
cell
type
like
identifi
plant
high
multipl
potenti
posit
influenc
scfv
product
use
plant
anoth
reason
use
model
plant
avail
genom
engin
plant
support
posttransl
modif
compat
mammalian
express
protein
use
nonconvent
plant
group
alga
bryophyt
shown
good
protein
express
platform
option
scfv
express
plant
heterolog
express
gene
transient
stabl
stabli
transform
plant
transgen
integr
genom
pass
success
gener
result
product
transgen
continu
present
throughout
plant
bodi
specif
tissu
target
express
transient
express
transgen
express
protein
without
proper
integr
genom
transgen
transfer
next
gener
vector
specif
design
transient
express
variou
target
gene
establish
agroinfiltr
method
use
commonli
establish
transient
transgen
report
scfv
express
plant
deal
report
compar
scfvfc
format
scfv
format
express
better
twofold
increas
n
benthamiana
nicotiana
benthamiana
hairi
root
cultur
use
success
express
glycoengin
scfv
antibodi
base
mab
rituximab
addit
plant
growth
regul
found
enhanc
secret
recombin
antibodi
cultur
vessel
purifi
effect
bound
antigen
surfac
human
daudi
cell
transient
express
favor
protein
need
within
short
span
time
compar
larg
quantiti
express
protein
advers
effect
host
cell
overexpress
use
differ
promot
recombin
protein
express
system
gener
review
extens
promot
use
heterolog
express
system
vari
significantli
natur
activ
locat
mode
action
studi
reveal
plant
signal
peptid
promot
avail
express
guid
store
protein
almost
cellular
extracellular
target
one
major
disadvantag
plant
use
express
platform
plantspecif
secondari
modif
ad
protein
may
make
immunogen
henc
useless
mani
applic
addit
plantspecif
nglycan
take
place
endoplasm
reticulum
golgi
apparatu
prevent
protein
reach
target
keep
protein
away
modif
done
mainli
use
two
method
use
glycosyl
mutant
develop
model
plant
arabidopsi
nicotiana
facilit
similar
glycosyl
mammalian
system
engin
construct
incorpor
signal
peptid
either
retain
express
protein
er
target
protein
extern
medium
apoplast
space
tissu
kdel
signal
sequenc
use
extens
plant
recombin
scfv
express
retain
protein
er
lumen
er
retent
mani
occas
found
beneficiari
protein
express
show
higher
stabil
concentr
er
signal
peptid
deriv
arabidopsi
seed
storag
protein
commonli
use
plant
target
scfv
seed
report
use
signal
peptid
like
pectat
lyas
sp
murin
signal
peptid
msp
plant
express
system
secret
scfv
express
transient
express
perform
mostli
leav
stabl
transgen
direct
protein
express
specif
tissu
express
recombin
protein
seed
consid
suitabl
strategi
scfv
express
scfv
target
oil
bodi
seed
purifi
less
difficulti
studi
report
seed
shelf
life
scfv
also
increas
seedspecif
promot
phaseolu
vulgari
legumin
unknown
seed
protein
oleosin
use
target
scfv
seed
model
plant
zakharov
cowork
studi
seed
direct
express
report
gene
use
four
seedspecif
promot
differ
transgen
plant
includ
tobacco
pea
narbon
bean
linse
studi
propos
engin
promot
impart
specif
either
pollen
seed
refut
ambigu
nonspecif
express
anoth
studi
scfv
target
surfac
epitop
sheep
gut
nematod
trichostrongylu
colubriformi
fuse
trimer
polyoleosin
express
arabidopsi
seed
use
seedspecif
oleosin
promot
fusion
product
accumul
oil
bodi
rang
nearli
total
seed
protein
show
similar
express
profil
oleosin
gome
cowork
use
sumo
small
ubiquitinlik
modifi
fusion
protein
scfv
metalloproteinas
bothrop
asper
increas
protein
express
n
benthamiana
advantag
target
protein
express
seed
along
technic
detail
express
strategi
issu
consid
product
pharmaceut
applic
explain
well
one
pioneer
review
seedspecif
express
recombin
protein
express
certain
recombin
protein
heterolog
system
may
caus
minor
sever
side
effect
host
topic
studi
well
prokaryot
express
system
compar
mammalian
plant
express
system
prokaryot
especi
induc
express
recombin
protein
host
cell
affect
due
target
protein
b
induc
c
toxic
express
protein
studi
transcriptom
level
plant
tri
relat
effect
transgen
express
physiolog
physic
statu
transgen
plant
found
major
differ
observ
transgen
plant
compar
nontransgen
control
condit
use
de
wild
cowork
studi
effect
recombin
antibodi
express
transcriptom
proteom
thaliana
seed
collect
postanthesi
studi
reveal
upregul
gene
correspond
protein
fold
modif
transloc
vesicl
transport
protein
degrad
observ
product
recombin
antibodi
er
trigger
er
stress
caus
disturb
normal
cellular
homeostasi
compar
cho
chines
hamster
ovari
express
system
difficult
predict
express
effici
protein
model
plant
system
exampl
quantiti
protein
mgkg
fresh
tissu
express
n
benthamiana
leav
vari
mgkg
scfv
mgkg
antiompd
scfv
chang
observ
model
system
two
differ
target
protein
due
multipl
factor
involv
codon
usag
mrna
stabil
proteolysi
report
plant
express
system
structur
specif
charact
protein
play
crucial
role
stabil
within
host
proteolysi
mechan
adopt
host
maintain
function
integr
variou
method
like
proteas
inhibitor
supplement
suspens
cultur
medium
stabil
agent
knock
proteas
encod
gene
subcellular
target
recombin
protein
use
fusion
protein
major
strategi
reduc
proteolysi
anoth
report
two
format
scfv
scfv
scfvfc
ompd
protein
salmonella
typhimurium
express
n
benthamiana
scfv
version
show
greater
express
scfvfc
detail
studi
necessari
prove
structur
functionbas
target
protein
cleavag
express
host
unlik
prokaryot
system
express
transgen
success
gener
matter
concern
higher
organ
like
anim
plant
factor
control
express
transgen
plant
includ
copi
number
place
integr
physiolog
statu
target
tissu
natur
protein
sort
signal
subcellular
local
report
studi
express
antibodyantibodi
fragment
transgen
progeni
three
four
gener
one
studi
protein
antitnf
alpha
scfv
concentr
old
seed
respect
gener
concentr
protein
gener
mgg
especi
homozyg
genotyp
recent
strategi
target
transient
express
tissuebas
approach
may
adopt
protein
need
special
care
inconsist
biolog
efficaci
one
major
problem
biosimilar
protein
express
plant
scfv
encod
gene
express
tobacco
cytoplasm
ertarget
protein
measur
affin
scfv
antigen
indic
reduct
compar
parent
fab
reduc
environ
cytosol
consid
nonfavor
disulfid
bond
format
protein
transient
express
scfv
tobacco
protoplast
result
absenc
disulfid
bond
reduc
activ
scfv
express
cytosol
stabli
transform
tobacco
plant
disulfid
bond
show
excel
biolog
activ
one
recent
studi
publish
phoolcharoen
et
al
transient
express
scfv
rabi
viru
alon
conjug
central
nervou
systemspecif
peptid
show
mice
infect
viru
treat
scfv
scfvpeptid
molecul
could
cross
bloodbrain
barrier
scfvpeptid
specif
bound
target
confirm
bioavail
scfv
allerg
reaction
glycoprotein
lead
product
ige
antibodi
human
be
mani
studi
conduct
past
link
presenc
ige
antibodi
patient
use
inform
diagnosi
treatment
allerg
diseas
surprisingli
none
studi
indic
clear
correl
presenc
ige
blood
clinic
effect
immunogen
induc
plantspecif
glycan
one
main
object
plantbas
product
biotherapeut
contrari
argument
experiment
evid
show
plantspecif
glycan
interfer
immun
system
time
rather
benefici
nglycosyl
pattern
plant
glycoprotein
differ
anim
plantderiv
recombin
protein
nlink
glycosyl
termin
core
sialic
acid
residu
absent
plant
olink
glycosyl
also
differ
plant
anim
taligluceras
alfa
tga
express
carrot
cell
acid
betaglucosidas
use
treatment
gaucher
diseas
rup
cowork
studi
immunogen
effect
tga
one
year
among
adult
pediatr
patient
result
indic
patient
develop
antiplantglycan
antibodi
detail
studi
variou
diseas
paramet
show
treatment
effici
enzym
replac
therapi
use
safeti
indic
well
within
limit
observ
substanti
result
obtain
landri
cowork
use
plantbas
vaccin
accord
result
patient
receiv
vaccin
avian
influenza
develop
serum
antibodi
plantspecif
sugar
posit
effect
human
glycosyl
plantderiv
antibodi
report
case
zmapp
zmapp
cocktail
three
mab
express
glycoengin
n
benthamiana
use
treatment
ebola
viru
medicin
approv
fda
usag
ebola
outbreak
west
africa
phase
ii
clinic
trial
four
countri
complet
zmapp
exampl
synthesi
idiotypespecif
vaccin
nonhodgkin
lymphoma
follicular
lymphoma
synthes
mammalian
biosimilar
protein
glycosyl
machineri
host
plant
need
manipul
glycosyl
mutant
develop
thaliana
model
plant
protein
express
similar
glycosyl
mammalian
cell
even
though
minor
differ
glycosyl
scfv
express
thaliana
show
biolog
effect
similar
parent
antibodi
phasei
clinic
trial
assess
safeti
immunogen
recombin
idiotypespecif
scfv
develop
nonhodgkin
lymphoma
nicotiana
mccormick
cowork
observ
vaccin
induc
idiotypespecif
immun
respons
monger
cowork
studi
effect
vaccin
piglet
gastroenter
viru
infect
differ
concentr
scfv
without
adjuv
low
high
dose
vaccin
without
adjuv
make
signific
advers
effect
also
report
differ
glycosyl
impart
immunogen
underglycosyl
nativ
protein
along
aberr
glycosyl
scfv
notic
antimbp
scfv
express
glycosyl
mutant
alg
thaliana
anoth
studi
antiha
loos
et
al
ha
ehf
also
alter
glycosyl
pattern
scfv
aberr
deposit
erspecif
chaperon
report
protein
target
er
scfvfc
express
n
benthamiana
glycoengin
xylosefructos
nglycosyl
devoid
plantspecif
nglycosyl
biolog
activ
studi
purifi
scfvfc
exhibit
improv
bind
affin
compar
nonengin
form
scfv
rituximab
cytotox
induc
antibodydepend
cellmedi
pathway
complementari
depend
pathway
strongli
enhanc
data
indic
major
factor
prevent
use
plant
system
cost
associ
downstream
purif
recombin
protein
rather
posttransl
chang
associ
plant
express
develop
express
system
may
secret
protein
medium
make
purif
process
easi
resolv
issu
valid
cost
factor
done
sever
recombin
protein
includ
mab
evalu
feasibl
develop
process
commerci
purpos
everincreas
demand
antibodi
fragment
commerci
market
continu
search
econom
viabl
platform
product
regard
worthwhil
look
plant
express
system
establish
costeffect
product
platform
search
point
concern
rectifi
seedbas
propag
plant
timeconsum
transient
express
protein
plant
attain
day
n
benthamiana
transient
express
system
gener
recombin
antibodi
influenza
viru
timebound
manner
agroinfiltr
method
took
less
week
includ
time
need
downstream
process
get
purifi
antibodi
indic
transform
purif
method
establish
product
platform
recombin
protein
made
whenev
need
technolog
great
signific
condit
like
sudden
surg
season
epidem
ebola
argument
cost
factor
focu
mani
research
paper
publish
recent
unlik
uniform
exist
among
microbi
mammalian
express
system
term
growth
requir
amount
protein
express
strategi
adopt
purif
plant
express
system
exhibit
signific
differ
among
plant
offer
option
select
site
express
leav
whole
plant
seed
type
system
hairi
root
plant
suspens
cultur
purif
method
therefor
studi
fail
deriv
conclus
gener
express
system
look
differ
mani
aspect
schillberg
cowork
observ
plant
system
rel
low
yield
inconsist
product
ineffici
largescal
downstream
process
tobacco
chloroplast
gfp
express
concentr
mgg
fw
ngg
fw
tobacco
cellbas
express
produc
gfp
around
studi
estim
product
cost
g
human
antibodi
nicotiana
around
euro
result
also
shown
total
process
cost
downstream
process
cultiv
account
antibodi
purifi
cell
total
process
cost
downstream
process
also
observ
product
rate
cell
lower
whole
tobacco
plant
anoth
studi
estim
product
cost
antibodi
use
plant
express
platform
eurog
accord
previou
report
cho
cell
product
cost
around
eurog
antibodi
sometim
low
eurog
accord
lim
et
al
product
cost
g
typic
glycosyl
protein
use
differ
express
system
pichia
pastori
mammalian
cell
escherichia
coli
pseudomona
fluorescen
around
usd
respect
sugar
profil
attach
protein
influenc
activ
due
less
complex
machineri
mammalian
cell
plant
amen
specif
glycan
modif
tuse
cowork
use
superpro
design
model
softwar
predict
technoeconom
advantag
plant
express
system
use
human
butyrylcholinesteras
cellulos
two
enzym
divers
origin
applic
studi
propos
signific
cost
advantag
plant
express
compar
convent
product
system
abovesaid
candid
molecul
buyel
review
addit
stream
incorpor
plant
product
platform
increas
commerci
potenti
target
protein
biomass
exploit
improv
revenu
side
stream
plantbas
process
doubl
revenu
depend
addit
product
develop
integr
approach
plant
endow
addit
featur
like
rhizosecret
yet
exploit
full
potenti
secret
select
correct
express
platform
fastgrow
easi
manipul
genet
need
less
mainten
cost
provis
reduc
downstream
process
cost
mab
express
complex
may
possibl
look
antibodi
fragment
offer
similar
activ
mab
heterolog
express
antibodi
fragment
plant
effect
lowcost
strategi
largescal
pharmaceut
product
major
concern
system
like
develop
stabl
transgen
express
protein
purif
protein
structur
function
similar
parent
antibodi
scale
product
platform
studi
detail
measur
tackl
issu
relat
topic
develop
ad
advantag
like
absenc
anim
pathogen
target
express
organellesstorag
organ
longterm
storag
express
protein
target
tissu
feasibl
oral
consumpt
facilit
purif
case
oil
bodi
coupl
express
develop
genomeedit
express
platform
make
plantmad
recombin
protein
lucr
high
demand
therapeut
antibodi
human
veterinari
therapeut
magnitud
product
need
enhanc
combin
advantag
plant
express
system
along
favor
featur
antibodi
fragment
mab
may
pave
path
rapid
biosynthesi
antibodybas
diagnosistherapeut
increas
avail
product
may
lead
make
usag
afford
